SERAC1 gene mutation presented with markedly alpha fetoprotein elevation: Case report
dc.authorid | 0000-0002-5728-3895 | en_US |
dc.authorid | 0000-0003-3886-3808 | en_US |
dc.authorid | 0000-0003-0962-2116 | en_US |
dc.authorid | 0000-0002-6079-5517 | en_US |
dc.authorid | 0000-0003-0848-2561 | en_US |
dc.contributor.author | Bayrak, Harun | |
dc.contributor.author | Sezer, Abdullah | |
dc.contributor.author | Danış, Ayşegül | |
dc.contributor.author | Özhan, Selen Has | |
dc.contributor.author | Yıldız, Harun | |
dc.contributor.author | Kılıç, Mustafa | |
dc.date.accessioned | 2024-02-13T11:06:59Z | |
dc.date.available | 2024-02-13T11:06:59Z | |
dc.date.issued | 2023 | en_US |
dc.department | BAİBÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü | en_US |
dc.description.abstract | SERAC1 (Serine active site-containing 1, MIM: 614725) gene is located on chromosome 6q25.3. SERAC1 protein is a membrane protein containing 654 amino acids. It contains a serine lipase domain and belongs to the PGAG-like protein family, which plays a crucial role in mitochondrial function. SERAC1 protein has a role in intracellular cholesterol and phospholipid trafficking of action [1]. SERAC1 mutations as the cause of MEGD(H)EL syndrome (MIM: 614739) are an autosomal recessive mitochondrial disease associated with 3-methylglutaconic aciduria, dystonia, deafness, (hepatopathy), encephalopathy, with Leigh-like syndrome. | en_US |
dc.identifier.citation | Bayrak, H., Sezer, A., Danış, A., Özhan, S. H., Yıldız, H., & Kılıç, M. (2023). SERAC1 gene mutation presented with markedly alpha fetoprotein elevation: case report. Acta Neurologica Belgica, 1-3. | en_US |
dc.identifier.doi | 10.1007/s13760-023-02305-y | |
dc.identifier.endpage | 3 | en_US |
dc.identifier.issn | 0300-9009 | |
dc.identifier.issn | 2240-2993 | |
dc.identifier.pmid | 37306826 | en_US |
dc.identifier.scopus | 2-s2.0-85161688809 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.startpage | 1 | en_US |
dc.identifier.uri | http://dx.doi.org/10.1007/s13760-023-02305-y | |
dc.identifier.uri | https://hdl.handle.net/20.500.12491/12014 | |
dc.identifier.wos | WOS:001007495700001 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.institutionauthor | Danış, Ayşegül | |
dc.language.iso | en | en_US |
dc.publisher | Springer Heidelberg | en_US |
dc.relation.ispartof | Acta Neurologica Belgica | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | 3-MGA | en_US |
dc.subject | Alpha Fetoprotein | en_US |
dc.subject | MEGDHEL | en_US |
dc.subject | Mitochondrial Diseases | en_US |
dc.subject | SERAC1 | en_US |
dc.title | SERAC1 gene mutation presented with markedly alpha fetoprotein elevation: Case report | en_US |
dc.type | Article | en_US |